Pub. Rec./Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases

Summary

The measure would require the Florida Department of Health to publish an annual report on experimental treatments for terminal or rare diseases, but would make the patients' health information and drug pricing details confidential and not subject to public‑records requests. It aims to protect the privacy of patients pursuing experimental therapies. The bill did not pass and died in committee.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share